Cargando…
C9orf72 intermediate expansions of 24–30 repeats are associated with ALS
The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European population. In most people, the repeat length is 2, but in people with ALS, hundreds to thousands of repeats may be observed. A...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637621/ https://www.ncbi.nlm.nih.gov/pubmed/31315673 http://dx.doi.org/10.1186/s40478-019-0724-4 |
_version_ | 1783436280345919488 |
---|---|
author | Iacoangeli, Alfredo Al Khleifat, Ahmad Jones, Ashley R. Sproviero, William Shatunov, Aleksey Opie-Martin, Sarah Morrison, Karen E. Shaw, Pamela J. Shaw, Christopher E. Fogh, Isabella Dobson, Richard J. Newhouse, Stephen J. Al-Chalabi, Ammar |
author_facet | Iacoangeli, Alfredo Al Khleifat, Ahmad Jones, Ashley R. Sproviero, William Shatunov, Aleksey Opie-Martin, Sarah Morrison, Karen E. Shaw, Pamela J. Shaw, Christopher E. Fogh, Isabella Dobson, Richard J. Newhouse, Stephen J. Al-Chalabi, Ammar |
author_sort | Iacoangeli, Alfredo |
collection | PubMed |
description | The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European population. In most people, the repeat length is 2, but in people with ALS, hundreds to thousands of repeats may be observed. A small proportion of people have an intermediate expansion, of the order of 20 to 30 repeats in size, and it remains unknown whether intermediate expansions confer risk of ALS in the same way that massive expansions do. We investigated the association of this intermediate repeat with ALS by performing a meta-analysis of four previously published studies and a new British/Alzheimer’s Disease Neuroimaging Initiative dataset of 1295 cases and 613 controls. The final dataset comprised 5071 cases and 3747 controls. Our meta-analysis showed association between ALS and intermediate C9orf72 repeats of 24 to 30 repeats in size (random-effects model OR = 4.2, 95% CI = 1.23–14.35, p-value = 0.02). Furthermore, we showed a different frequency of the repeat between the northern and southern European populations (Fisher’s exact test p-value = 5 × 10(− 3)). Our findings provide evidence for the association between intermediate repeats and ALS (p-value = 2 × 10(− 4)) with direct relevance for research and clinical practice by showing that an expansion of 24 or more repeats should be considered pathogenic. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0724-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6637621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66376212019-07-25 C9orf72 intermediate expansions of 24–30 repeats are associated with ALS Iacoangeli, Alfredo Al Khleifat, Ahmad Jones, Ashley R. Sproviero, William Shatunov, Aleksey Opie-Martin, Sarah Morrison, Karen E. Shaw, Pamela J. Shaw, Christopher E. Fogh, Isabella Dobson, Richard J. Newhouse, Stephen J. Al-Chalabi, Ammar Acta Neuropathol Commun Research The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European population. In most people, the repeat length is 2, but in people with ALS, hundreds to thousands of repeats may be observed. A small proportion of people have an intermediate expansion, of the order of 20 to 30 repeats in size, and it remains unknown whether intermediate expansions confer risk of ALS in the same way that massive expansions do. We investigated the association of this intermediate repeat with ALS by performing a meta-analysis of four previously published studies and a new British/Alzheimer’s Disease Neuroimaging Initiative dataset of 1295 cases and 613 controls. The final dataset comprised 5071 cases and 3747 controls. Our meta-analysis showed association between ALS and intermediate C9orf72 repeats of 24 to 30 repeats in size (random-effects model OR = 4.2, 95% CI = 1.23–14.35, p-value = 0.02). Furthermore, we showed a different frequency of the repeat between the northern and southern European populations (Fisher’s exact test p-value = 5 × 10(− 3)). Our findings provide evidence for the association between intermediate repeats and ALS (p-value = 2 × 10(− 4)) with direct relevance for research and clinical practice by showing that an expansion of 24 or more repeats should be considered pathogenic. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-019-0724-4) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-17 /pmc/articles/PMC6637621/ /pubmed/31315673 http://dx.doi.org/10.1186/s40478-019-0724-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Iacoangeli, Alfredo Al Khleifat, Ahmad Jones, Ashley R. Sproviero, William Shatunov, Aleksey Opie-Martin, Sarah Morrison, Karen E. Shaw, Pamela J. Shaw, Christopher E. Fogh, Isabella Dobson, Richard J. Newhouse, Stephen J. Al-Chalabi, Ammar C9orf72 intermediate expansions of 24–30 repeats are associated with ALS |
title | C9orf72 intermediate expansions of 24–30 repeats are associated with ALS |
title_full | C9orf72 intermediate expansions of 24–30 repeats are associated with ALS |
title_fullStr | C9orf72 intermediate expansions of 24–30 repeats are associated with ALS |
title_full_unstemmed | C9orf72 intermediate expansions of 24–30 repeats are associated with ALS |
title_short | C9orf72 intermediate expansions of 24–30 repeats are associated with ALS |
title_sort | c9orf72 intermediate expansions of 24–30 repeats are associated with als |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637621/ https://www.ncbi.nlm.nih.gov/pubmed/31315673 http://dx.doi.org/10.1186/s40478-019-0724-4 |
work_keys_str_mv | AT iacoangelialfredo c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT alkhleifatahmad c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT jonesashleyr c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT sprovierowilliam c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT shatunovaleksey c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT opiemartinsarah c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT morrisonkarene c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT shawpamelaj c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT shawchristophere c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT foghisabella c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT dobsonrichardj c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT newhousestephenj c9orf72intermediateexpansionsof2430repeatsareassociatedwithals AT alchalabiammar c9orf72intermediateexpansionsof2430repeatsareassociatedwithals |